Your browser doesn't support javascript.
loading
Geographical prevalence of SARS-CoV-2 variants, August 2020 to July 2021.
Chan, Wai Sing; Lam, Yuk Man; Law, Janet Hei Yin; Chan, Tsun Leung; Ma, Edmond Shiu Kwan; Tang, Bone Siu Fai.
Afiliação
  • Chan WS; Department of Pathology, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong, China.
  • Lam YM; Department of Pathology, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong, China.
  • Law JHY; Department of Pathology, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong, China.
  • Chan TL; Department of Pathology, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong, China.
  • Ma ESK; Department of Pathology, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong, China.
  • Tang BSF; Department of Pathology, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong, China. Bone.SF.Tang@hksh.com.
Sci Rep ; 12(1): 4704, 2022 03 18.
Article em En | MEDLINE | ID: mdl-35304553
We extracted one-year genomic data (August 2020-July 2021) from GISAID EpiCoV™ database and estimated monthly proportions of 11 SARS-CoV-2 variants in various geographical regions. From continental perspective, Delta VOC predominated in Africa, Asia, Europe, North America and Oceania, with proportions of 67.58-98.31% in July 2021. In South America, proportion of Delta VOC (23.24%) has been approaching the predominant yet diminishing Gamma VOC (56.86%). We further analyzed monthly data on new COVID-19 cases, new deaths, vaccination status and variant proportions of 6 countries. Delta VOC predominated in all countries except Brazil (Gamma VOC) in July 2021. In most occasions, rise and predominance of Alpha, Beta, Gamma, Delta and Zeta variants were accompanied with surges of new cases, especially after the time point of major lineage interchange. The ascending phases of new cases lasted for 1-5 months with 1.69- to 40.63-fold peak growth, whereas new death tolls varied with regional vaccination status. Our data suggested surges of COVID-19 cases might be predicted from variant surveillance data. Despite vaccine breakthroughs by Delta VOC, death tolls were more stable in countries with better immunization coverage. Another takeaway is the urgent need to improve vaccine efficacy against Delta and emerging variants.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Prevalence_studies / Risk_factors_studies Limite: Humans País/Região como assunto: America do sul / Brasil Idioma: En Revista: Sci Rep Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Prevalence_studies / Risk_factors_studies Limite: Humans País/Região como assunto: America do sul / Brasil Idioma: En Revista: Sci Rep Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido